As big pharma companies flock to drugs that destroy harmful proteins, the UK protein degradation specialist Amphista Therapeutics has bagged two landmark collaboration deals with the heavyweights Bristol Myers Squibb and Merck.
Big pharma companies are piling onto biotechs developing…
Source: www.labiotech.eu – Read more
